Summary
CCK-8 and its desulfated analog (des-CCK-8) increase insulin secretion from isolated rat pancreatic islets in the presence of 8.3 mM glucose in a concentration-dependent manner. Proglumide (dl-4-benzamido-N,N-dipropylglutaramic acid), a gastrin and cholecystokinin (CCK) receptor antagonist, inhibits the synergistic effect of CCK on insulin release in the presence of 8.3 mM glucose; its EC50 (half-maximal effective concentration) was 1.2±0.4 mM. Its effect is specific in that is does not inhibit the glucose- or GIP (glucose dependent insulinotropic peptide) induced insulin secretion to a major degree. CCK-8, des-CCK-8 and proglumide compete for binding of 125I-CCK-33 to rat pancreatic islets; the IC50 of proglumide was 0.8 mM. The affinity of proglumide is in the range of both its EC50 for inhibition of insulin secretion and its IC50 in other in vitro systems tested so far (exocrine pancreas, gall bladder, cortex). Its inhibitory effect presumably is not a gastrin antagonizing effect since gastrin does not stimulate insulin secretion. The data therefore indicate that proglumide should be monitored for diabetic effects in vivo.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahren B, Lundquist, I (1981) Effects of two cholecystokinin variants CCK-39 and CCK-8 on basal and stimulated insulin secretion. Acta Diabet Lat 18:345–356
Arigoni et al. (1980) Proglumide: human pharmacokinetics after single and repeated intravenous or intramuscular administration. IV Int. Proglumide Symposium, Hamburg
Ashton WD (1972) The logit-transformation. With special reference to its uses in bioassay. Griffin, London
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248–254
Chiodo IA, Bunney BS (1983) Proglumide: Selective antagonism of excitatory effects of cholecystokinin in central nervous system. Sience 219:1149–1151
Davison JS, Najafi-Farashah A (1982) Antagonism of the action of cholecystokinin-pancreozymin (CCK-PZ) and related peptides by proglumide in the guinea pig ileum and gall bladder. J Physiol 329:39P-40P
Dupré J, Curtis JD, Unger RH, Wadell RW, Beck JC (1960) Effect of secretin, pancreozymin or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man. J Clin Invest 48:745:757
Galcone M, Moise G, Casula PL, Bignamini AA (1981) Eine zweijährige Studie zum Auftreten von Ulcusrezidiven nach Proglumid-Therapie. Med Welt 32:173–175
Gardner JD, Jensen RT, Collins SM, Hahne WF, Lemp GF (1982) Proglumide: a new member of a new class of cholecystokinin receptor antagonists. 5th International Symposium on Proglumide, Gastrin Receptor Antagonist, Stockholm
Hahne WF, Jensen RT, Lemp GF, Gardner JD (1981) Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists. Proc Natl Acad Sci 78:6304–6308
Kaplita PV, Roebuck BD (1984) Proglumide antagonizes the stimulation of rabbit gallbladder by cholecystokinin. Arch Int Pharmacodyn Ther 269:271–276
Kuo W-N, Hodgins DS, Kuo JF (1973) Adenylate cyclase in islets of Langerhans. J Biol Chem 248:2705–2711
Lacy PE, Kostianovski M (1967) Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16:35–39
Magous R, Bali JP (1982) Effects of proglumide and benzotript on the parietal cell functions. 5th International Symposium on Proglumide, Gastrin Receptor Antagonist, Stockholm
Magous R, Bali JP (1983) Evidence that proglumide and benzotript antagonize secretagogue stimulation of isolated gastric parietal cells, Regul Pept 7:233–241
Niederaus C, Ferrell LD, Grendell JH (1985) Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretion. Gastroenterology 88:1192–1204
Okuda S (1972) Lecture at IX. International Congress for Gastroenterology, Paris
Otsuki M, Sakamoto C, Yuu H, Maeda M, Morita S, Ohki A, Kobayashi N, Terashi K, Okano K, Baba S (1979) Discrepancies between the doses of cholecystokinin- or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas. J Clin Invest 63:478–484
Rehfeld JF (1971) Effect of gastrin and its C-terminal tetrapeptide on insulin secretion in man. Acta Endocrinol 66:169–176
Sakamoto C, Goldfine ID, Roach E, Williams JA (1985) Localization of saturable CCK binding sites in rat pancreatic islets by light and electron microscope autoradiography. Diabetes 34:390–394
Sankaran H, Deveney CW, Goldfine ID, Williams JA (1979) Preparation of biologically active radioiodinated cholestokinin for radioreceptor assay and radioimmunoassay. J Biol Chem 254:9349–9351
Siegel EG, Creutzfeldt W (1985) Stimulation of insulin release in isolated rat islets by GIP in physiological concentrations and its relation to islet cyclic AMP content. Diabetologia 28:857–861
Szecowka J, Lins PE, Effendic S (1982) Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats. Endocrinology 110:1268–1272
Steigerwalt R, Goldfine ID, Williams JA (1984) Characterization of cholecystokinin receptors on bovine gallbladder membranes. Am J Physiol 247:G709-G714
Van Dijk A, Richards JG, Trzeciak A, Gillessen D, Möhler H (1984) Cholecystokinin receptors: Biochemical demonstration and autoradiographical localization in rat brain and pancreas using 3H cholecystokinin-8 as radioligand. J Neuroscience 4:1021–1033
Verspohl EJ, Ammon HPT (1980) Evidence for presence of insulin receptors in rat islets of Langerhans. J Clin Invest 65:1230–1237
Verspohl EJ, Ammon HPT, Goldfine ID, Williams JA (1985) Evidence for specific cholecystokinin receptors in isolated rat pancreatic islets. 45th Annual Meeting of the American Diabetes Association (Abstract)
Verspohl EJ, Ammon HPT, Goldfine ID, Williams JA (1986) Evidence for specific cholecystokinin receptors in isolated rat pancreatic islets. Diabetes (in press)
Vigna SR, Szecowka J, Williams JA (1985) Do antagonists of pancreatic cholecystokinin receptors interact with CNS cholecystokinin receptors. Brain Res 343:394–397
Williams JA, Bailey A, Steigerwalt RW (1983) Effects of proglumide on pancreatic acinar cell function. Digestion 27:227–233
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Verspohl, E.J., Wunderle, G., Ammon, H.P.T. et al. Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol. 332, 284–287 (1986). https://doi.org/10.1007/BF00504868
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00504868